{"id":3957,"date":"2017-05-12T14:30:00","date_gmt":"2017-05-12T22:30:00","guid":{"rendered":"https:\/\/drugpolicy.ca\/?post_type=publications&#038;p=3957\/"},"modified":"2018-03-19T00:16:10","modified_gmt":"2018-03-19T08:16:10","slug":"la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements","status":"publish","type":"publications","link":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/","title":{"rendered":"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements"},"content":{"rendered":"<p>Le Canada a urgemment besoin de politiques compl\u00e8tes sur la r\u00e9duction des m\u00e9faits et de se d\u00e9barrasser du mod\u00e8le rat\u00e9 et co\u00fbteux de la prohibition des drogues qui a ravag\u00e9 tant de vies en catalysant la propagation du VIH et du virus de l\u2019h\u00e9patite C (VHC), en stimulant un recours trop fr\u00e9quent \u00e0 l\u2019incarc\u00e9ration et en cr\u00e9ant des conditions propices \u00e0 l\u2019\u00e9pid\u00e9mie de d\u00e9c\u00e8s par surdoses qui se poursuit. Une approche de r\u00e9duction des m\u00e9faits doit inclure des mesures pour att\u00e9nuer les pr\u00e9judices susceptibles de s\u2019associer \u00e0 certaines substances (l\u00e9gales ou ill\u00e9gales) ainsi qu\u2019un engagement \u00e0 faire cesser les pr\u00e9judices d\u00e9coulant de l\u2019existence et de l\u2019application de lois et politiques punitives relatives aux drogues. Les politiques en mati\u00e8re de drogues doivent \u00eatre guid\u00e9es par les donn\u00e9es probantes, les objectifs de la sant\u00e9 publique ainsi qu\u2019un engagement au respect des droits humains des personnes qui consomment des drogues. Le gouvernement f\u00e9d\u00e9ral peut, et devrait, agir d\u00e8s maintenant sur plusieurs fronts afin de prot\u00e9ger la sant\u00e9 et les droits humains de tous les Canadiens et Canadiennes, en particulier ceux et celles qui sont le plus \u00e0 risque de subir des pr\u00e9judices.<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2017\/05\/Harm-Reduction-in-Canada-FR.pdf\">Lisez la publication en cliquant ici<\/a><\/p>\n<p><strong>Actions imm\u00e9diates requises des gouvernements<\/strong><\/p>\n<ol>\n<li>Mettre \u00e0 l\u2019\u00e9chelle les mesures de r\u00e9ponse aux surdoses.<\/li>\n<li>\u00a0Am\u00e9liorer l\u2019acc\u00e8s au traitement de la d\u00e9pendance aux opio\u00efdes.<\/li>\n<li>\u00a0\u00c9largir rapidement l\u2019acc\u00e8s aux services salvateurs de consommation plus s\u00e9curitaire<\/li>\n<li>\u00a0Mettre en \u0153uvre un programme complet de r\u00e9duction des m\u00e9faits en prison<\/li>\n<li>\u00a0Financer la r\u00e9duction des m\u00e9faits, y compris les r\u00e9ponses communautaire<\/li>\n<li>Cesser la \u00ab guerre aux drogues \u00bb et la criminalisation des personnes qui consomment des drogues<\/li>\n<\/ol>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2017\/05\/Harm-Reduction-in-Canada-FR.pdf\">Harm Reduction in Canada-FR<\/a><\/p>\n<p>&#8211; Canadian Drug Policy Coalition, the HIV\/AIDS Legal Network, the Canadian Association of People Who Use Drugs, Harm Reduction International<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Canada a urgemment besoin de politiques compl\u00e8tes sur la r\u00e9duction des m\u00e9faits et de se d\u00e9barrasser du mod\u00e8le rat\u00e9 et co\u00fbteux de la prohibition des drogues qui a ravag\u00e9 tant de vies en catalysant la propagation du VIH et du virus de l\u2019h\u00e9patite C (VHC), en stimulant un recours trop fr\u00e9quent \u00e0 l\u2019incarc\u00e9ration et [&hellip;]<\/p>\n","protected":false},"featured_media":3974,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","tags":[],"publication-types":[],"class_list":["post-3957","publications","type-publications","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Le Canada a urgemment besoin de politiques compl\u00e8tes sur la r\u00e9duction des m\u00e9faits et de se d\u00e9barrasser du mod\u00e8le rat\u00e9 et co\u00fbteux de la prohibition des drogues qui a ravag\u00e9 tant de vies en catalysant la propagation du VIH et du virus de l\u2019h\u00e9patite C (VHC), en stimulant un recours trop fr\u00e9quent \u00e0 l\u2019incarc\u00e9ration et [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-19T08:16:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2017\/05\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png\" \/>\n\t<meta property=\"og:image:width\" content=\"501\" \/>\n\t<meta property=\"og:image:height\" content=\"326\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/\",\"name\":\"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png\",\"datePublished\":\"2017-05-12T22:30:00+00:00\",\"dateModified\":\"2018-03-19T08:16:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png\",\"contentUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png\",\"width\":501,\"height\":326},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mail.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/about\\\/publication\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/","og_locale":"fr_FR","og_type":"article","og_title":"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition","og_description":"Le Canada a urgemment besoin de politiques compl\u00e8tes sur la r\u00e9duction des m\u00e9faits et de se d\u00e9barrasser du mod\u00e8le rat\u00e9 et co\u00fbteux de la prohibition des drogues qui a ravag\u00e9 tant de vies en catalysant la propagation du VIH et du virus de l\u2019h\u00e9patite C (VHC), en stimulant un recours trop fr\u00e9quent \u00e0 l\u2019incarc\u00e9ration et [&hellip;]","og_url":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/","og_site_name":"Canadian Drug Policy Coalition","article_modified_time":"2018-03-19T08:16:10+00:00","og_image":[{"width":501,"height":326,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2017\/05\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/","url":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/","name":"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/#primaryimage"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2017\/05\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png","datePublished":"2017-05-12T22:30:00+00:00","dateModified":"2018-03-19T08:16:10+00:00","breadcrumb":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/#primaryimage","url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2017\/05\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png","contentUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2017\/05\/CDPC-Home-Page_HR-Infographic-FR_May15-2017_501x326px.png","width":501,"height":326},{"@type":"BreadcrumbList","@id":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/la-reduction-des-mefaits-au-canada-actions-immediates-requises-des-gouvernements\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mail.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/www.drugpolicy.ca\/fr\/about\/publication\/"},{"@type":"ListItem","position":3,"name":"La r\u00e9duction des m\u00e9faits au Canada \u2013 Actions imm\u00e9diates requises des gouvernements"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/publications\/3957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/publications"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=3957"}],"version-history":[{"count":0,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/publications\/3957\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/3974"}],"wp:attachment":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=3957"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=3957"},{"taxonomy":"publication-types","embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/publication-types?post=3957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}